CIBC Private Wealth Group, LLC - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 83 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
CIBC Private Wealth Group, LLC ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$962,308
-68.8%
93,428
-50.0%
0.00%
-33.3%
Q2 2023$3,082,090
+17.6%
187,020
-34.6%
0.00%0.0%
Q1 2023$2,621,318
+163.4%
286,170
+105.9%
0.00%0.0%
Q4 2022$995,276
+24.9%
139,005
-12.6%
0.00%
+50.0%
Q3 2022$797,000
+97.8%
159,005
-3.6%
0.00%
+100.0%
Q2 2022$403,000
-44.3%
165,005
+55.6%
0.00%
-50.0%
Q1 2022$724,000
-45.8%
106,071
-35.9%
0.00%
-33.3%
Q4 2021$1,336,000
-17.5%
165,3550.0%0.00%
-25.0%
Q3 2021$1,620,000
+45.7%
165,3550.0%0.00%
+33.3%
Q2 2021$1,112,000
-25.6%
165,3550.0%0.00%
-25.0%
Q1 2021$1,495,000
+244.5%
165,355
+154.4%
0.00%
+300.0%
Q4 2020$434,000
+32.3%
65,0050.0%0.00%0.0%
Q3 2020$328,000
-71.1%
65,005
-56.7%
0.00%
-75.0%
Q4 2019$1,133,000
+81.6%
150,0000.0%0.00%
+100.0%
Q3 2019$624,000
+43.8%
150,0000.0%0.00%0.0%
Q2 2019$434,000150,0000.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q4 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 985,210$10,345,0006.10%
Broadfin Capital, LLC 3,568,122$37,465,0005.54%
JW Asset Management, LLC 444,439$4,667,0003.42%
ARMISTICE CAPITAL, LLC 1,688,000$17,724,0002.09%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,655,494$38,383,0001.73%
FALCON POINT CAPITAL, LLC 661,490$6,284,0000.91%
KNOTT DAVID M 158,555$1,665,0000.71%
Perceptive Advisors 3,098,010$32,530,0000.62%
Sio Capital Management, LLC 91,413$960,0000.50%
HEARTLAND ADVISORS INC 700,000$7,350,0000.48%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders